Concepedia

Ryan G. Keddy

RG

Statistics

Publications

7

Citations

528

H-Index

7

Active since

1999

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

AbbVie (United States)

Ryan G. Keddy is an author at Abbott Fund specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1999–2018

7

Publications

7

Cyclopentannulation of 3-Alkylindoles:  A Synthesis of a Tetracyclic Subunit of the Kopsane Alkaloids

Dylan B. England, Timothy D. O. Kuss, Ryan G. Keddy et al. · The Journal of Organic Chemistry · 2001 · 150 citations

, , +14

Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A

David A. DeGoey, John T. Randolph, Dachun Liu et al. · Journal of Medicinal Chemistry · 2014 · 126 citations

, , +16

The annulation of 3-alkylindoles with 1,1-cyclopropanediesters

Michael A. Kerr, Ryan G. Keddy · Tetrahedron Letters · 1999 · 92 citations

, , +8

Highlights of the Structure–Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)

Rolf Wagner, John T. Randolph, Sachin Patel et al. · Journal of Medicinal Chemistry · 2018 · 53 citations · Full text

, , +17

Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists

Brian S. Brown, Ryan G. Keddy, Guo Zhu Zheng et al. · Bioorganic & Medicinal Chemistry · 2008 · 48 citations · Full text

, , +10

1–5 of 7